Business Description
Venus Medtech (Hangzhou) Inc
ISIN : CNE100003PJ8
Share Class Description:
HKSE:02500: Class HCompare
Compare
Traded in other countries / regions
02500.Hong KongVMTHF.USA IPO Date
2019-12-10Description
Venus Medtech (Hangzhou) Inc is engaged in the development and commercialization of transcatheter solutions for structural heart diseases. It has two TAVR products on the market, namely VenusA-Valve, and VenusA-Plus. VenusA-Valve is its first-generation TAVR device, which is used to treat severe Aortic Stenosis (AS) using a transcatheter approach. VenusA-Plus is an upgraded product of VenusA-Valve. Geographically majority of the revenue is derived from Mainland China.
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.95 | |||||
Equity-to-Asset | 0.66 | |||||
Debt-to-Equity | 0.28 | |||||
Debt-to-EBITDA | -1.51 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | -0.18 | |||||
Beneish M-Score | -2.41 | |||||
WACC vs ROIC |
Growth Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 15.3 | |||||
3-Year EBITDA Growth Rate | -47.9 | |||||
3-Year EPS without NRI Growth Rate | -47.8 | |||||
3-Year FCF Growth Rate | -27.7 | |||||
3-Year Book Growth Rate | -12.2 |
Momentum Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
14-Day RSI | 65.04 | |||||
12-1 Month Momentum % | -6.64 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2 | |||||
Quick Ratio | 1.86 | |||||
Cash Ratio | 0.97 | |||||
Days Inventory | 401.71 | |||||
Days Sales Outstanding | 248.1 | |||||
Days Payable | 80.66 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -1.4 | |||||
Shareholder Yield % | 5.86 |
Profitability Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 79.21 | |||||
Operating Margin % | -116.22 | |||||
Net Margin % | -143.22 | |||||
FCF Margin % | -177.65 | |||||
ROE % | -21.29 | |||||
ROA % | -14.26 | |||||
ROIC % | -17.25 | |||||
ROC (Joel Greenblatt) % | -77.68 | |||||
ROCE % | -15.68 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 4.58 | |||||
PB Ratio | 0.78 | |||||
Price-to-Tangible-Book | 1.68 | |||||
EV-to-EBIT | -3.43 | |||||
EV-to-Forward-EBIT | -9.26 | |||||
EV-to-EBITDA | -4.22 | |||||
EV-to-Forward-EBITDA | -23.32 | |||||
EV-to-Revenue | 4.7 | |||||
EV-to-Forward-Revenue | 1.85 | |||||
EV-to-FCF | -2.65 | |||||
Price-to-Net-Current-Asset-Value | 19.38 | |||||
Earnings Yield (Greenblatt) % | -29.15 | |||||
FCF Yield % | -38.52 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Venus Medtech (Hangzhou) Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil HK$) | 537.454 | ||
EPS (TTM) (HK$) | -1.761 | ||
Beta | 1.16 | ||
Volatility % | 45.18 | ||
14-Day RSI | 65.04 | ||
14-Day ATR (HK$) | 0.000007 | ||
20-Day SMA (HK$) | 5.62 | ||
12-1 Month Momentum % | -6.64 | ||
52-Week Range (HK$) | 3.74 - 7.83 | ||
Shares Outstanding (Mil) | 441.01 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Venus Medtech (Hangzhou) Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Venus Medtech (Hangzhou) Inc Stock Events
Event | Date | Price(HK$) | ||
---|---|---|---|---|
No Event Data |
Venus Medtech (Hangzhou) Inc Frequently Asked Questions
What is Venus Medtech (Hangzhou) Inc(HKSE:02500)'s stock price today?
The current price of HKSE:02500 is HK$5.62. The 52 week high of HKSE:02500 is HK$7.83 and 52 week low is HK$3.74.
When is next earnings date of Venus Medtech (Hangzhou) Inc(HKSE:02500)?
The next earnings date of Venus Medtech (Hangzhou) Inc(HKSE:02500) is .
Does Venus Medtech (Hangzhou) Inc(HKSE:02500) pay dividends? If so, how much?
Venus Medtech (Hangzhou) Inc(HKSE:02500) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |